http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012062247-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1817a002a31e2f27d02482d79517aacc |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
| filingDate | 2010-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17721ee0e6d2c4f0b40b05ca3f22840e |
| publicationDate | 2012-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2012062247-A |
| titleOfInvention | Viral therapeutic agent |
| abstract | A safe peanut seed coat extract, grape seed extract, and azuki bean extract capable of effectively suppressing enterovirus 71 are provided. Pharmaceutical compositions used for the treatment or prevention of pathologies induced by enterovirus 71 infection are provided. A pharmaceutical for use in the treatment or prevention of a pathological condition induced by enterovirus 71 comprising one or more extracts selected from peanut seed coat extract, grape seed extract and azuki bean extract as an active ingredient A composition is provided. [Selection figure] None |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105560254-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109394682-A |
| priorityDate | 2010-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.